The prognostic value of IDH mutations and MGMT promoter status in secondary high-grade gliomas
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The prognostic value of IDH mutations and MGMT promoter status in secondary high-grade gliomas
Authors
Keywords
-
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume 110, Issue 3, Pages 325-333
Publisher
Springer Nature
Online
2012-09-27
DOI
10.1007/s11060-012-0977-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IDH mutations as an early and consistent marker in low-grade astrocytomas WHO grade II and their consecutive secondary high-grade gliomas
- (2012) Tareq A. Juratli et al. JOURNAL OF NEURO-ONCOLOGY
- Evidence for Sequenced Molecular Evolution of IDH1 Mutant Glioblastoma From a Distinct Cell of Origin
- (2011) Albert Lai et al. JOURNAL OF CLINICAL ONCOLOGY
- Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas
- (2010) Christian Hartmann et al. ACTA NEUROPATHOLOGICA
- Molecular Classification of Low-Grade Diffuse Gliomas
- (2010) Young-Ho Kim et al. AMERICAN JOURNAL OF PATHOLOGY
- IDH1 and IDH2 Mutations Are Prognostic but not Predictive for Outcome in Anaplastic Oligodendroglial Tumors: A Report of the European Organization for Research and Treatment of Cancer Brain Tumor Group
- (2010) M. J. van den Bent et al. CLINICAL CANCER RESEARCH
- Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas
- (2009) Christian Hartmann et al. ACTA NEUROPATHOLOGICA
- IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas
- (2009) S. Nobusawa et al. CLINICAL CANCER RESEARCH
- Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas
- (2009) Marc Sanson et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
- (2009) Michael Weller et al. Nature Reviews Neurology
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epigenetic markers in human gliomas: prospects for therapeutic intervention
- (2008) Luke B Hesson et al. Expert Review of Neurotherapeutics
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
- Molecular profiling of oligodendrogliomas: Impact on prognosis, treatment, and future directions
- (2008) Douglas E. Ney et al. Current Oncology Reports
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now